Cargando…

“Prescribing for the whole person”: A qualitative study exploring prescribing pharmacist views on type 2 diabetes management in New Zealand

BACKGROUND: Pharmacist prescribers have comprehensive pharmacotherapy knowledge that can be useful for management of complex health conditions such as type 2 diabetes, yet the number of pharmacist prescribers working in New Zealand primary care is low. AIM: To explore the experiences of pharmacist p...

Descripción completa

Detalles Bibliográficos
Autores principales: Norman, Kimberley, Cassim, Shemana, Papa, Valentina, Te-Karu, Leanne, Clark, Penny, Mullins, Hilde, Chepulis, Lynne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552232/
https://www.ncbi.nlm.nih.gov/pubmed/37794403
http://dx.doi.org/10.1186/s12913-023-09877-8
_version_ 1785115916726435840
author Norman, Kimberley
Cassim, Shemana
Papa, Valentina
Te-Karu, Leanne
Clark, Penny
Mullins, Hilde
Chepulis, Lynne
author_facet Norman, Kimberley
Cassim, Shemana
Papa, Valentina
Te-Karu, Leanne
Clark, Penny
Mullins, Hilde
Chepulis, Lynne
author_sort Norman, Kimberley
collection PubMed
description BACKGROUND: Pharmacist prescribers have comprehensive pharmacotherapy knowledge that can be useful for management of complex health conditions such as type 2 diabetes, yet the number of pharmacist prescribers working in New Zealand primary care is low. AIM: To explore the experiences of pharmacist prescribers in supporting type 2 diabetes management in New Zealand primary care. METHODS: Qualitative research design using semi-structured interviews with six pharmacist prescribers working in NZ primary care. Thematic analysis guided this study and themes were finalised with the wider research team. RESULTS: Three major themes were identified: team approach, health inequity and the role of a pharmacist prescriber. This study found that pharmacist prescribers may improve health equity by providing advanced pharmacotherapy knowledge within a wider primary care team to support complex patient needs and understanding the wider social determinants of health that impact effective diabetes management. Participants reportedly had more time to spend with patients (than GPs or nurses) and could also contribute to improving health outcomes by directly educating and empowering patients. CONCLUSION: The views of pharmacist prescribers have seldom been explored and this study suggests that their role may be under-utilised in primary care. In particular, pharmacist prescribers can provide specialist prescribing (and often mobile) care, and may contribute to improving health outcomes and reducing inequity when used as part of a multi-disciplinary team.
format Online
Article
Text
id pubmed-10552232
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105522322023-10-06 “Prescribing for the whole person”: A qualitative study exploring prescribing pharmacist views on type 2 diabetes management in New Zealand Norman, Kimberley Cassim, Shemana Papa, Valentina Te-Karu, Leanne Clark, Penny Mullins, Hilde Chepulis, Lynne BMC Health Serv Res Research BACKGROUND: Pharmacist prescribers have comprehensive pharmacotherapy knowledge that can be useful for management of complex health conditions such as type 2 diabetes, yet the number of pharmacist prescribers working in New Zealand primary care is low. AIM: To explore the experiences of pharmacist prescribers in supporting type 2 diabetes management in New Zealand primary care. METHODS: Qualitative research design using semi-structured interviews with six pharmacist prescribers working in NZ primary care. Thematic analysis guided this study and themes were finalised with the wider research team. RESULTS: Three major themes were identified: team approach, health inequity and the role of a pharmacist prescriber. This study found that pharmacist prescribers may improve health equity by providing advanced pharmacotherapy knowledge within a wider primary care team to support complex patient needs and understanding the wider social determinants of health that impact effective diabetes management. Participants reportedly had more time to spend with patients (than GPs or nurses) and could also contribute to improving health outcomes by directly educating and empowering patients. CONCLUSION: The views of pharmacist prescribers have seldom been explored and this study suggests that their role may be under-utilised in primary care. In particular, pharmacist prescribers can provide specialist prescribing (and often mobile) care, and may contribute to improving health outcomes and reducing inequity when used as part of a multi-disciplinary team. BioMed Central 2023-10-04 /pmc/articles/PMC10552232/ /pubmed/37794403 http://dx.doi.org/10.1186/s12913-023-09877-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Norman, Kimberley
Cassim, Shemana
Papa, Valentina
Te-Karu, Leanne
Clark, Penny
Mullins, Hilde
Chepulis, Lynne
“Prescribing for the whole person”: A qualitative study exploring prescribing pharmacist views on type 2 diabetes management in New Zealand
title “Prescribing for the whole person”: A qualitative study exploring prescribing pharmacist views on type 2 diabetes management in New Zealand
title_full “Prescribing for the whole person”: A qualitative study exploring prescribing pharmacist views on type 2 diabetes management in New Zealand
title_fullStr “Prescribing for the whole person”: A qualitative study exploring prescribing pharmacist views on type 2 diabetes management in New Zealand
title_full_unstemmed “Prescribing for the whole person”: A qualitative study exploring prescribing pharmacist views on type 2 diabetes management in New Zealand
title_short “Prescribing for the whole person”: A qualitative study exploring prescribing pharmacist views on type 2 diabetes management in New Zealand
title_sort “prescribing for the whole person”: a qualitative study exploring prescribing pharmacist views on type 2 diabetes management in new zealand
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552232/
https://www.ncbi.nlm.nih.gov/pubmed/37794403
http://dx.doi.org/10.1186/s12913-023-09877-8
work_keys_str_mv AT normankimberley prescribingforthewholepersonaqualitativestudyexploringprescribingpharmacistviewsontype2diabetesmanagementinnewzealand
AT cassimshemana prescribingforthewholepersonaqualitativestudyexploringprescribingpharmacistviewsontype2diabetesmanagementinnewzealand
AT papavalentina prescribingforthewholepersonaqualitativestudyexploringprescribingpharmacistviewsontype2diabetesmanagementinnewzealand
AT tekaruleanne prescribingforthewholepersonaqualitativestudyexploringprescribingpharmacistviewsontype2diabetesmanagementinnewzealand
AT clarkpenny prescribingforthewholepersonaqualitativestudyexploringprescribingpharmacistviewsontype2diabetesmanagementinnewzealand
AT mullinshilde prescribingforthewholepersonaqualitativestudyexploringprescribingpharmacistviewsontype2diabetesmanagementinnewzealand
AT chepulislynne prescribingforthewholepersonaqualitativestudyexploringprescribingpharmacistviewsontype2diabetesmanagementinnewzealand